Safety and efficacy of recombinant botulinum toxin type A (Eveotox®) in patients with post-stroke upper limb spasticity: Results from a Phase Ib/II clinical trial - Rongrong Lu; Lingjing Jin; Jianzhong Xiong; Lixin Zhang; Yaling Liu; Leilei Xu; Rui Wu; Jianhua Tang; Liandong Zhao; Lihua Dong; Weifeng Luo; Yu Pan; et al. (Toxicon, 2026)